Key result
Increasing cardiac troponin T levels in patients with Acute Respiratory Distress Syndrome are significantly associated with increased 60-day mortality (adjusted HR 1.45 per 1 ng/mL increase).
Why the study?
Do elevated cardiac troponin T levels predict increased 60-day mortality in patients with ARDS?
Population
177 patients with Acute Respiratory Distress Syndrome (ARDS) at a tertiary-care academic medical center
Comparison
Elevated cardiac troponin T levels measured… vs Lower or undetectable cTnT levels
Design
Cohort
Follow-up
60 days
Authors
Loading...
May aid ARDS mortality risk stratification; leaves open whether troponin identifies modifiable pathways or warrants intervention.
Cohort (n=177)
No
Do elevated cardiac troponin T levels predict increased 60-day mortality in patients with ARDS?
Hazard Ratio: 1.45 (95% CI 1.17–1.81)
p-value: p=0.001
Elevated cardiac troponin T levels are common in ARDS patients and independently predict increased 60-day mortality and worse clinical outcomes, despite no association with ECG evidence of coronary ischemia.
Rivara et al. (2012) conducted a cohort in Acute Respiratory Distress Syndrome (ARDS) (n=177). Elevated cardiac troponin T (cTnT) levels vs. Lower or undetectable cTnT levels was evaluated on 60-day mortality (HR 1.45, 95% CI 1.17-1.81, p=0.001). Increasing cardiac troponin T levels in patients with Acute Respiratory Distress Syndrome are significantly associated with increased 60-day mortality (adjusted HR 1.45 per 1 ng/mL increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: